Skip to main content
. 2023 Sep 30;51(2):496–509. doi: 10.1007/s00259-023-06437-4

Fig. 6.

Fig. 6

Examples of time-activity curves from six patients with different glioma types and grades. The similar curve characteristics (increasing) for SUVpeak for all tumors indicate that dynamic anti-3-[18F]FACBC PET cannot be used to differentiate between glioma types and grades (Bkg, background)